Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Saven

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|October 17, 2018
Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemiaMunveer S Bhangoo, Alan Saven
The New England Journal of Medicine|December 18, 2024
Hairy-Cell LeukemiaDavid J Hermel, Alan Saven
Blood|March 29, 2003
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemiaJorge Nieva, Kelly Bethel, Alan Saven
JAMA Oncology|October 30, 2015
Current Therapy and New Directions in the Treatment of Hairy Cell Leukemia: A ReviewAditya Sarvaria, Zheng Topp, Alan Saven
Leukemia & Lymphoma|October 10, 2009
Cladribine in the treatment of hairy cell leukemia: initial and subsequent resultsEdward Huynh, Darren Sigal, Alan Saven
Leukemia & Lymphoma|September 1, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemiaDanielle Brazel, David J Hermel, Alan Saven
Best Practice & Research. Clinical Haematology|April 3, 2003
Cladribine in the treatment of hairy-cell leukaemiaGrant R Goodman, Ernest Beutler, Alan Saven
Current Opinion in Hematology|June 12, 2003
Hairy cell leukemia: an updateGrant R Goodman, Kelly J Bethel, Alan Saven
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2024
Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the MolecularDanielle Brazel, David Hermel, Pranav Gandhi, et al.
Leukemia & Lymphoma|April 21, 2011
Development of cladribine at Scripps for hairy cell leukemia and current resultsMelissa L Torrey, Darren S Sigal, Alan Saven
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|October 17, 2018
Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemiaMunveer S Bhangoo, Alan Saven
The New England Journal of Medicine|December 18, 2024
Hairy-Cell LeukemiaDavid J Hermel, Alan Saven
Blood|March 29, 2003
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemiaJorge Nieva, Kelly Bethel, Alan Saven
JAMA Oncology|October 30, 2015
Current Therapy and New Directions in the Treatment of Hairy Cell Leukemia: A ReviewAditya Sarvaria, Zheng Topp, Alan Saven
Leukemia & Lymphoma|October 10, 2009
Cladribine in the treatment of hairy cell leukemia: initial and subsequent resultsEdward Huynh, Darren Sigal, Alan Saven
Leukemia & Lymphoma|September 1, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemiaDanielle Brazel, David J Hermel, Alan Saven
Best Practice & Research. Clinical Haematology|April 3, 2003
Cladribine in the treatment of hairy-cell leukaemiaGrant R Goodman, Ernest Beutler, Alan Saven
Current Opinion in Hematology|June 12, 2003
Hairy cell leukemia: an updateGrant R Goodman, Kelly J Bethel, Alan Saven
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2024
Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the MolecularDanielle Brazel, David Hermel, Pranav Gandhi, et al.
Leukemia & Lymphoma|April 21, 2011
Development of cladribine at Scripps for hairy cell leukemia and current resultsMelissa L Torrey, Darren S Sigal, Alan Saven
Pageof 7